BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

CAPS Rating: 1 out of 5

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

Recs

0
Player Avatar pchop123 (79.66) Submitted: 1/2/2013 11:04:27 AM : Underperform Start Price: $1.60 BCRX Score: -4.02

Sell on any surge

Featured Broker Partners


Advertisement